Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tracleer for Tourniquet-associated Hypertension in TKA
NCT03229694Phase 4Unknown
- Sponsor
- Xuzhou Medical University
- Start
- Aug 2017
- Primary completion
- Apr 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bosentan in hypertension (HTN), sponsored by Xuzhou Medical University. Status: unknown.
02
Drugs
bosentan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03229694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229694.